Overview

Perioperative Lidocaine and Ketamine in Abdominal Surgery

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The investigators propose to test the hypothesis that perioperative infusions of lidocaine and/or ketamine reduce opioid consumption and pain scores in adults recovering from elective inpatient abdominal surgery.
Phase:
Phase 3
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Ketamine
Lidocaine